Submit Manuscript  

Article Details


Treatment of Alzheimers Disease: The Beginning of a New Era Dale Schenk, ISOA - October 5th-6th, 2005

[ Vol. 3 , Issue. 3 ]

Author(s):

Dale Schenk   Pages 177 - 177 ( 1 )

Abstract:


Keywords:

neuronal degeneration, CSF, Abeta immunotherapy, beta amyloid peptide, tau kinases

Affiliation:

Chief Scientific Officer, Elan Corporation, 800 Gateway Blvd., South San Francisco, CA 9480, USA.



Read Full-Text article